7Baggers
 regulus therapeutics stock hits 52-week low at $1.16  MSN Tue, 23 Sep 2025 02:33:53 GMT
 published on: 2025-09-17 04:10:14  خودرو بانک Wed, 17 Sep 2025 00:40:42 GMT
 novartis to buy us biotech tourmaline bio for us$1.4 billion  The Business Times Tue, 09 Sep 2025 08:22:00 GMT
 novartis to acquire tourmaline bio  The Pharma Letter Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 16:05:42  خودرو بانک Wed, 03 Sep 2025 16:29:17 GMT
 published on: 2025-08-26 14:47:21  beatles.ru Tue, 26 Aug 2025 11:49:08 GMT
 san diego biotech m&a activity (so far)  Fred Grier | Substack Tue, 26 Aug 2025 07:00:00 GMT
 novartis weighs deal for biotech avidity biosciences, ft reports  Yahoo Finance Wed, 06 Aug 2025 15:41:37 GMT

Regulus Therapeutics Inc
(NASDAQ:RGLS) 

RGLS stock logo

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the trea...

Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends